Home » Topics » Regulatory » Patents

Patents
RSS

Betta Pharmaceuticals discloses new HIF-2alpha inhibitors

Jan. 11, 2022

AC Immune synthesizes NLRP3 inflammasome inhibitors

Jan. 11, 2022

Researchers present new F-BODIPY dyes for cancer

Jan. 11, 2022

Sato Pharmaceutical patents new HPGDS inhibitors

Jan. 11, 2022

Autobahn Therapeutics discloses thyroid hormone receptor agonists

Jan. 11, 2022

Volastra Therapeutics identifies ENPP1 inhibitors

Jan. 10, 2022

Incyte synthesizes new JAK2 V617F inhibitors

Jan. 10, 2022

Gossamer Bio presents DGKA and/or DGKZ inhibitors

Jan. 10, 2022

The Vanderbilt University divulges new muscarinic M5 receptor antagonists

Jan. 10, 2022

Dana-Farber Cancer Institute patents UCP1 activators

Jan. 10, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...